Daniel K. Spiegelman, EVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 3,298 shares at $89.14 ($294K) on 2016-06-06, disclosed to the SEC on 2016-06-08.
Open-market sale of $294k BMRN by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.14 | 1,649 | $147K | 50.0% |
| 2 | $89.14 | 1,649 | $147K | 50.0% |
| Total | $89.14 avg | 3,298 | $294K | 100% |
| Filing → |
| MYGN | SELL | 2022-06-06 | $124K | — | Filing → |
| MYGN | SELL | 2021-06-17 | $192K | — | Filing → |
| MYGN | SELL | 2021-06-01 | $414K | — | Filing → |